Business Standard

Aspira Pathlab & Diagnostics Share Price

Know More
BSENSE

30.80 0.37 (1.22%)

04:01 PM,24th Apr 2024
Stock not traded

BSE : 540788

NSE :

Sector : Health care

ISIN Code : INE500C01017

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-Apr-2024 | 04:01 PM IST

Market Cap (₹ Cr)

32

Turnover (₹ Cr)

0.00

Volume (Shares)

380

Face Value

10

52-WK High

49.50

52-WK High Date

25-Aug-2023

52-WK Low

22.76

52-WK Low Date

22-Jun-2023

All Time High

124.15

All Time High Date

12-Nov-2021

All Time Low

14.15

All Time Low Date

28-Feb-2018

Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd 1973. The Company is engaged into the business of running owning managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'. The Company issued 2943000 equity shares of Rs. 10/- each at an issue price of Rs. 17/- per share (including share premium of Rs...
Read More

Aspira Pathlab Announcement

<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Aspira Pathlab & Diagnostics Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L85100MH1973PLC289209</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2023-2024</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2023-20242024-2025</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2022-20232023-2024</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Krupali Shah</td></tr><tr><td>Designation :-</td><td>Company Secretary</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Balkrishna Talawadekar </td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 09/04/2024<br/><br/></div>

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Aspira Pathlab & Diagnostics Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85100MH1973PLC289209</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Krupali Shah <br/> Designation: Company Secretary <br/> EmailId: krupali.shah@aspiradiagnostics.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Balkrishna Talawadekar <br/> Designation: Chief Financial Officer <br/> EmailId: balkrishna.talawadekar@aspiradiagnostics.com</div> </div> <div> <br/> Date: 09/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Aspira Pathlab & Diagnostics Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

32

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

2.80

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]11.00
P/B Ratio (₹) [S]2.80

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

30.80

30.82

Week Low/High

29.10

32.00

Month Low/High

27.50

37.00

Year Low/High

22.76

50.00

All time Low/High

14.15

124.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.65%%1.251.15%
1 Month%%1.401.38%
3 Month-11.55%%3.934.42%
6 Month-16.98%%14.3716.18%
1 Year-6.67%%22.9726.26%
3 Year%%54.2556.21%

Company Info

Company Information

Managing Director & CEO : Pankaj Jashwant Shah

Non Executive Director : Arvind Karsandas Bhanushali

Independent Director : Mangala Radha Krishnan Prabhu

Chairman & Independent Directo : Haseeb Drabu

Non Executive Director : Nikunj Mange

Independent Director : Subhash Raghunath Salunke

Independent Director : A C Mahajan

Independent Director : Manas Mengar

Registered Office: Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W),Mumbai,Maharashtra-400086 Ph: 91-22-71975756/5656

Email:info@aspiradiagnostics.com

URL:http://www.aspiradiagnostics.com